I think the EGX merger is a great thing for this company - in...

I think the EGX merger is a great thing for this company - in the long term.

In the short term, we have more dilution, which can only lead to trading sideways, or down. The private-equity premium is now a thing of the past, and the generous price paid for Evogenix will no doubt weigh on the share price.

Until we have Phase I trial results, my price target is $1. Maybe $2 within 2-3 years.